Publication | Open Access

Safety and Efficacy of First-Line Bevacizumab with Chemotherapy in Asian Patients with Advanced Nonsquamous NSCLC: Results from the Phase IV MO19390 (SAiL) Study

Advanced Nonsquamous NsclcOncologyMedicineMetronomic TherapyPhase Iv Mo19390PharmacotherapyMetronomic ChemotherapyCancer TreatmentAsian PatientsPharmacologyLung Cancer